NCT05788744View on ClinicalTrials.gov

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2030

Conditions
Resectable Pancreatic Cancer
Interventions
DIAGNOSTIC_TEST

ctDNA

ctDNA guided surveillance

Trial Locations (5)

2100

RECRUITING

Copenhagen University Hospital - Rigshospitalet, Copenhagen

2730

NOT_YET_RECRUITING

Copenhagen University Hospital - Herlev and Gentofte, Herlev

5000

NOT_YET_RECRUITING

Odense Universitetshospital, Odense

8000

NOT_YET_RECRUITING

Aarhus Universitetshospital, Aarhus

9000

NOT_YET_RECRUITING

Aalborg Universitetshospital, Aalborg

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

University of Copenhagen

OTHER

collaborator

Odense University Hospital

OTHER

lead

Copenhagen University Hospital at Herlev

OTHER